Neuropace Inc (NPCE NASDAQ) stock market data APIs
$10.5415
0.49(4.6%)
as of October 16, 2025
Try our APIs with
free plan!
Neuropace Inc Financial Data Overview
Price chart is built with
Anychart
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Prev. Close
10.5415
Open
11.0301
High
11.2885
Low
10.6548
52 wk Range
5.45-18.975
Market Cap
352 M
Shares Outstanding
33 081 K
Revenue
88 570 K
EPS
-0.26
Beta
1.915
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 88 570 K
- EBITDA: -19 659 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
3 Stocks That May Be Undervalued By Up To 34.5%
As the U.S. stock market navigates a landscape marked by strong bank earnings and renewed trade tensions with China, investors are keeping a close eye on potential opportunities amidst the volatility....
3 Stocks Estimated To Be Up To 30.1% Below Intrinsic Value
Amid recent market volatility, the U.S. stock indices have experienced significant fluctuations, with a notable surge following President Trump's softened stance on China. As investors navigate these ...
3 Stocks That Might Be Trading Below Intrinsic Value By Up To 48.3%
In the current U.S. market landscape, stocks have rebounded as President Trump softened his stance on China, leading to a positive response from major indices like the Nasdaq and S&P 500. Amidst this ...
XPEL And 2 Stocks That Could Be Trading Below Estimated Value
As U.S.-China trade tensions flare up once more, major stock indexes have experienced notable declines, with the Nasdaq falling 3.6% and the S&P 500 down by 2.7% in a single session. In such volatile ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
